There are 2 papers on pleuroparenchymal fibroelastosis in aging research: 2 observational studies in people.
2 papers study it1 more mentions it3 findings
See all 3 papers on pleuroparenchymal fibroelastosis
“Progressive PPFE independently associated with mortality in both LCS cohorts (NLST: Hazard Ratio (HR)=1.25, 95% Confidence Interval (CI): 1.01–1.56, p=0.042”
- Humans2
Associations
3Antibiotic and steroid use
upin humans1
1 study
Antibiotic and steroid use
upin humans1
Pleuroparenchymal fibroelastosis is associated with antibiotic and steroid use in SUMMIT cohort (IRR 1.55).
“increased antibiotic and steroid use (IRR=1.55, p=0.010)”
Humansin SUMMIT cohort
Association of Progressive PPFE and Mortality in Lung Cancer Screening Cohorts
arXivPreprint
Respiratory admissions
upin humans1
1 study
Respiratory admissions
upin humans1
Pleuroparenchymal fibroelastosis is associated with respiratory admissions in SUMMIT cohort (IRR 2.79).
“progressive PPFE was strongly associated with higher respiratory admissions (IRR=2.79, p<0.001)”
Humansin SUMMIT cohort
Association of Progressive PPFE and Mortality in Lung Cancer Screening Cohorts
arXivPreprint
Mortality
upin humans1HR 1.25
1 study
Mortality
upin humans1HR 1.25
Pleuroparenchymal fibroelastosis predicts mortality in NLST cohort (HR 1.25, 95% CI 1.01–1.56).
“Progressive PPFE independently associated with mortality in both LCS cohorts (NLST: Hazard Ratio (HR)=1.25, 95% Confidence Interval (CI): 1.01–1.56, p=0.042”
Humansin NLST cohort
Association of Progressive PPFE and Mortality in Lung Cancer Screening Cohorts
arXivPreprint